Form 4 for PAHC PHIBRO ANIMAL HEALTH CORP
Accepted 2026-01-13 00:00:00 ET · period of report 2026-01-09 · accession 0001104659-26-003467 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-01-13 | 2026-01-09 | PAHC | BFI Co., LLC | 10% | S - Sale | $40.16 | -213 | 38.7K | -0.5% | -$8,554 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-01-09 | S | D | 213 | $40.16 | 38,659 | I See | — | — | (F2) The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of Phibro Animal Health Corporation (the "Issuer"), exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |